Matthias Bodenstedt
Financieel Directeur/CFO bij MOONLAKE IMMUNOTHERAPEUTICS
Vermogen: 34 M $ op 30-04-2024
Profiel
Matthias Bodenstedt is currently the Director and Chief Financial Officer at Moonlake Immunotherapeutics Ltd., Moonlake Immunotherapeutics AG, and MoonLake Immunotherapeutics.
Prior to this, he worked as a Partner at McKinsey & Co., Inc. from 2015 to 2021.
Bodenstedt received his undergraduate degree from the University of Hannover, his graduate degree from the University of Cambridge, and his MBA from Columbia Business School.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
15-03-2024 | 520 903 ( 0.87% ) | 22 M $ | 30-04-2024 | |
15-03-2024 | 294 473 ( 3.29% ) | 12 M $ | 30-04-2024 |
Actieve functies van Matthias Bodenstedt
Bedrijven | Functie | Begin |
---|---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Financieel Directeur/CFO | 05-04-2022 |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Financieel Directeur/CFO | 01-07-2021 |
Moonlake Immunotherapeutics Ltd. | Directeur/Bestuurslid | 01-09-2021 |
Eerdere bekende functies van Matthias Bodenstedt
Bedrijven | Functie | Einde |
---|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-06-2021 |
Opleiding van Matthias Bodenstedt
Columbia Business School | Masters Business Admin |
University of Cambridge | Graduate Degree |
University of Hannover | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
Moonlake Immunotherapeutics Ltd. |